ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
vrs37
|
7 |
1.9K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
7
|
1.9K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: AACR Conference Presentation
|
|
vrs37
|
7 |
1.9K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
7
|
1.9K
|
4
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
44
|
14K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
55K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
176
|
55K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
55K |
3 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
176
|
55K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
55K |
5 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
176
|
55K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
55K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
55K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
55K |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
55K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
vrs37
|
176 |
55K |
1 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
176
|
55K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
2 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
44
|
14K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
1 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
14K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
14K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
14K
|
6
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Update on ACCENT Trial in Pancreatic Cancer
|
|
vrs37
|
44 |
14K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
44
|
14K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Notification of upcoming expiry of Unlisted Options
|
|
vrs37
|
93 |
25K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
93
|
25K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
1 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
58
|
16K
|
1
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Successfully Passes Efficacy Interim Analysis
|
|
vrs37
|
279 |
92K |
2 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
279
|
92K
|
2
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
16K
|
3
|
|
ASX - By Stock
|
ATX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
vrs37
|
58 |
16K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
58
|
16K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
45K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
45K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
45K |
2 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
45K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
45K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
45K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
45K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
45K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
45K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
45K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
45K |
3 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
45K
|
3
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
45K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
153
|
45K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Completes $20M Placement
|
|
vrs37
|
153 |
45K |
0 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
153
|
45K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
222K |
0 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
640
|
222K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
222K |
2 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
640
|
222K
|
2
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
222K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
640
|
222K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
222K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
640
|
222K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Dimerix (ASX: DXB) Discussion Thread
|
|
vrs37
|
640 |
222K |
1 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
640
|
222K
|
1
|
|